Amphastar - AMPH Operating Margin

Official company branding of Amphastar (AMPH)

Amphastar Pharmaceuticals (AMPH) is developing a hybrid model, supplementing internal research with targeted acquisitions of mature assets. The operating profit margin history demonstrates a steady trajectory, with the indicator fixed at 18.70. High technological barriers ensure a predictable cash flow, while the production of complex injectable drugs for hospitals and pharmacies effectively diversifies market risks.

Amphastar Pharmaceuticals Inc (AMPH): Profitability of Operations from 07/04/2022 to 11/19/2026

Analytical breakdowns and data insights for company amphastar.com (AMPH)

- share price and consensus valuation forecast:
Fundamental company valuation:Amphastar
Finished products of Amphastar Pharmaceuticals

Full capacity utilization of Amphastar Pharmaceuticals (AMPH) for injectable production directly impacts cost management efficiency. This metric is calculated as the ratio of operating profit to revenue, isolating the effects of debt load and taxes. This allows for an assessment of the actual profitability of production processes and the quality of operational management. The stability of this metric confirms the business's resilience in the current cycle. EBIT margin dynamics help investors timely recognize the risk of reaching a peak in profitability.

Competitor analysis for Amphastar Pharmaceuticals

Operating Profitability haleon.com|Operating Profitability KVUE|Operating Profitability Verona Pharma (VRNA)|Jyong Biotech (MENS) - Operating Profitability Margin|Operating Margin LGND (Ligand Pharma)|Amneal Pharmaceuticals Inc - Operating Profitability|PRGO - Operating Profitability|Alvotech Corp (ALVO) - Operating Sales Margin|LQDA: Operating Margin|Operating Return on Sales glpg.com (GLPG)|Operating Profitability ANI Pharmaceuticals Inc|MNKD: Operating Profit Rate|Operating Profitability pacira.com (PCRX)|Operating Margin ARS Pharma (SPRY)|Theravance Biopharma - Operating Sales Margin|Operating Profit Ratio AQST (Aquestive Therapeutics)|SCPH: Operating Sales Margin|Operating Return on Sales Tectonic Therapeutic|TNXP: Operating Margin|SXT China (SXTC) - Operating Margin|Operating Profitability eupraxiapharma.com|BioHarvest Sciences (BHST) - Profitability of Operations|Operating Profitability Invizyne (EXOZ)|ORMP - Operating Return on Sales|Operating Margin ENTX (Entera Bio)|Operating Profitability Margin MindWalk Therapeutics|ABVC: Operating Sales Margin|CPIX - Operating Margin|QNTM (Quantum BioPharma) - Operating Sales Margin|Operating Profit Margin FGEN (FibroGen)|TELO (Telomir Pharmaceuticals Corp) - Operating Margin|Operating Margin ranitherapeutics.com|Operating Profitability Synergy CHC Corp. (SNYR)|Rallybio Corp - Return on Sales by Operating Profit|lexariabioscience.com - Operating Sales Margin|Operating Margin Pulmatrix Inc PULM|Pheton Holdings - Operating Margin|Operating Profit Margin APM|Lyra Therapeutics, Inc. (LYRA) - Operating Profitability|Operating Return on Sales Impact BioMedical, Inc. (IBO)|Operating Profitability TNF Pharma|YCBD: Operating Profit Rate|Operating Margin PRFX|CYTO - Operating Return on Sales|Operating Profitability Lipella LIPO|Operating Profit Ratio OPTN (OptiNose, Inc.)|PIRS - Operating Profitability|Procaps (PROC) - Operating Sales Margin|PTPI: Operating Margin|Qilian International (QLI) - Operating Margin|Operating Profitability Acelyrin, Inc.|Operating Margin TFF Pharmaceuticals, Inc.